CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-11-16 | RECTOR DAVID Director | Grant or award · Common Stock Options | +59,090 | 1,383,989 | ||
| 2012-11-16 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Options | +252,000 | 1,302,563 | ||
| 2012-11-16 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Options | +124,242 | 1,426,805 | ||
| 2012-08-08 | FORBES CHRISTOPHER Director | Conversion | +4,292,583 | $0.26 | $1.1M | 12,754,818 |
| 2012-08-08 | FORBES CHRISTOPHER Director | Conversion · Series B Convertible Preferred Stock | −1,000 | 0 | ||
| 2012-08-08 | Waksal Harlan Director | Conversion | +858,517 | $0.26 | $223K | 2,805,750 |
| 2012-08-08 | Waksal Harlan Director | Conversion · Series B Convertible Preferred Stock | −200 | 0 | ||
| 2012-05-16 | QUICK THOMAS C Director | Grant or award · Common Stock Option | +34,146 | 841,185 | ||
| 2012-05-16 | Van Hulst Jack Director | Grant or award · Common Stock Option | +31,708 | 967,917 | ||
| 2012-05-16 | Waksal Harlan Director | Grant or award · Common Stock Option | +46,342 | 1,702,330 | ||
| 2012-05-16 | BRACA JOHN N Director | Grant or award · Common Stock Option | +10,976 | 1,053,591 | ||
| 2012-05-16 | STALDER RUEDI Director | Grant or award · Common Stock Option | +40,244 | 1,472,657 | ||
| 2012-05-16 | RECTOR DAVID Director | Grant or award · Common Stock Option | +10,976 | 1,030,899 | ||
| 2012-05-16 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +35,366 | 1,050,563 | ||
| 2012-03-29 | Browne Leslie J President and CEO | Purchase | +10,000 | $0.26 | $3K | 19,000 |
| 2012-03-22 | Klaver Paul Edward 10% owner | Gift | −3,000,000 | 7,146,527 | ||
| 2012-03-22 | Klaver Paul Edward 10% owner | Gift | +3,000,000 | 10,146,527 | ||
| 2012-03-15 | Klaver Paul Edward 10% owner | Gift | −2,000,000 | 8,146,527 | ||
| 2012-03-15 | Klaver Paul Edward 10% owner | Gift | +2,000,000 | 10,146,527 | ||
| 2012-02-16 | BRACA JOHN N Director | Grant or award · Common Stock Option | +15,626 | 1,042,615 |
Page 24 of 26 · 511 trades